Supernus Pharmaceuticals
SUPN
#4015
Rank
โ‚ฌ2.49 B
Marketcap
43,28ย โ‚ฌ
Share price
1.38%
Change (1 day)
41.27%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Cash on Hand

Cash on Hand as of December 2025 : โ‚ฌ0.26 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company has โ‚ฌ0.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Supernus Pharmaceuticals - Cash on Hand chart (from 2009 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚ฌ0.26 B-39.72%
2024-12-31โ‚ฌ0.43 B89.07%
2023-12-31โ‚ฌ0.23 B-46.39%
2022-12-31โ‚ฌ0.43 B43.39%
2021-12-31โ‚ฌ0.29 B-12.69%
2020-12-31โ‚ฌ0.34 B10.88%
2019-12-31โ‚ฌ0.30 B-0.44%
2018-12-31โ‚ฌ0.31 B166.64%
2017-12-31โ‚ฌ0.11 B36.22%
2016-12-31โ‚ฌ85.67 M50.64%
2015-12-31โ‚ฌ56.87 M-6.94%
2014-12-31โ‚ฌ61.12 M2.7%
2013-12-31โ‚ฌ59.51 M-11.05%
2012-12-31โ‚ฌ66.91 M79%
2011-12-31โ‚ฌ37.38 M52.03%
2010-12-31โ‚ฌ24.58 M-47.05%
2009-12-31โ‚ฌ46.43 M7.51%
2008-12-31โ‚ฌ43.19 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ17.38 B 6,412.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ7.72 B 2,795.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ6.28 B 2,254.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ9.22 B 3,357.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚ฌ2.52 B 846.09%๐Ÿ‡บ๐Ÿ‡ธ USA